G
Giuseppe Paolisso
Researcher at Seconda Università degli Studi di Napoli
Publications - 518
Citations - 36557
Giuseppe Paolisso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 85, co-authored 479 publications receiving 33028 citations. Previous affiliations of Giuseppe Paolisso include National Institutes of Health & University of Udine.
Papers
More filters
Journal Article
Insulin resistance in cognitive impairment: the InCHIANTI study
C. Geroldi,Giovanni B. Frisoni,Giuseppe Paolisso,Stefania Bandinelli,M. Lamponi,Angela Marie Abbatecola,Orazio Zanetti,Jack M. Guralnik,Luigi Ferrucci +8 more
TL;DR: In this paper, the association between cognitive impairment, with and without subcortical features, and insulin resistance in an elderly community-dwelling population was tested. But the results were limited to individuals who had experienced stroke.
Book ChapterDOI
Cognitive Decline and Diabetes: A Focus on Linking Mechanisms
TL;DR: Hyperinsulinemia, IR, and other related conditions such as hypertension, dyslipidemia, and subclinical inflammation are related to a higher risk of cognitive impairment and dementia among diabetic patients, including mainly vascular dementia and late onset Alzheimer’s disease (LOAD).
Journal Article
Metabolic effects of nitrendipine.
TL;DR: In the nitrendipine-treated patients, both systolic and diastolic blood pressures were reduced significantly during treatment (from a mean of 180 to 155mmHg and 92 to 80 mmHg); heart rate did not change significantly; and results of a posttreatment oral glucose tolerance test were similar in the two treatment groups.
Journal ArticleDOI
Cirrhosis and frailty assessment in elderly patients: A paradoxical result.
Alessandro Federico,Giuseppe Gerardo Caprio,Anna Maria Dalise,Michelangela Barbieri,Marcello Dallio,Carmelina Loguercio,Giuseppe Paolisso,Maria Rosaria Rizzo +7 more
TL;DR: Clinical implication of this finding is that frailty assessment performed in the well-compensated liver cirrhosis patient can identify those cirrhotic patients who may benefit from tailored interventions similarly to non-cirrhotic elderly patients.
Journal ArticleDOI
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells
Nunzia D'Onofrio,Francesco Prattichizzo,Raffaele Marfella,Celestino Sardu,Elisabetta Di Martino,Lucia Scisciola,Lorenza Marfella,R. La Grotta,Chiara Frigé,Giuseppe Paolisso,Antonio Ceriello,Maria Luisa Balestrieri +11 more
TL;DR: In this paper , human aortic endothelial cells (TeloHAEC) were pre-treated with 100 µg/mL of the PCSK9i evolocumab and then exposed to 20 ng/mL IL-6, a major driver of cardiovascular diseases (CVD), in both naïve state and after siRNA-mediated suppression of the NAD-dependent deacetylase sirtuin-3 (SIRT3).